Trial Profile
A pilot phase 2 study of apabetalone in patients with Paroxysmal Nocturnal Hemoglobinuria
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 28 Sep 2015
Price :
$35
*
At a glance
- Drugs Apabetalone (Primary)
- Indications Paroxysmal nocturnal haemoglobinuria
- Focus Proof of concept; Therapeutic Use
- 28 Sep 2015 New trial record